9 Results for "

HIV-Tat

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "HIV-Tat" in MCE Product Catalog:

Cat. No.: HY-P3432
CAS No.: 2035480-78-3
DfTat is a disulfide-linked dimeric cell-penetrating peptide derived from HIV-TAT, and can be used as a delivery enhancer. DfTat is composed of natural amino acids and is rapidly degraded intracellularly. DfTat is taken up via macropinocytosis, accumulates in late endosomes, binds to late endosomal BMP lipids, and co-delivers cell-impermeable drugs into the cytosol of live cells via endocytosis after co-incubation. DfTat can be used in research related to cytosolic drug delivery .
loading...
    loading...
Cat. No.: HY-P1801A
Synonyms: Cys-[HIV-Tat (47-57)] TFA
Target:  

HIV Drug Derivative

Research Areas:  

Others

Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) TFA, TAT (HY-P0281) derivative, is a Cysteine (HY-Y0337)-tagged cell-penetrating peptide (CPP) derived from the HIV TAT protein. Cys-TAT(47-57) TFA can be used for the research for the research of drug delivery .
loading...
    loading...
Cat. No.: HY-P10839
CAS No.: 371915-62-7
Target:  

NF-κB

Research Areas:  

Inflammation/Immunology

NBD peptide inhibits NF-κB signaling pathway through inhibition of the NEMO-IKK complex combination. NBD peptide exhibits anti-inflammatory efficacy through block of pro-inflammatory cytokines production. NBD peptide exhibits immunosuppressive activity through regulation of immune cells. NBD peptide enhances its transmembrane ability by combining with cell-penetrating peptide HIV-TAT .
loading...
    loading...
Cat. No.: HY-P1801
CAS No.: 583836-55-9
Synonyms: Cys-[HIV-Tat (47-57)]
Target:  

HIV Drug Derivative

Research Areas:  

Others

Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]), TAT (HY-P0281) derivative, is a Cysteine (HY-Y0337)-tagged cell-penetrating peptide (CPP) derived from the HIV TAT protein. Cys-TAT(47-57) can be used for the research for the research of drug delivery .
loading...
    loading...
Cat. No.: HY-175535
CAS No.: 1940118-42-2
SRI-32743 is an allosteric human dopamine transporter (hDAT) modulator (IC50=9.86 μM). SRI-32743 is promising for research of HIV-Tat-induced neurotoxicity .
loading...
    loading...
Cat. No.: HY-P5320
Target:  

Apoptosis

Research Areas:  

Others

TAT-BH4 (Bcl-xL) localized mainly at the mitochondria, prevents apoptotic cell death. TAT-BH4 (Bcl-xL) is a fusion peptide that combines the N-terminal cysteine conjugated protein transduction domain of HIV TAT protein (amino acids 49 to 57) with the Bcl-xL BH4 peptide. TAT-BH4 can be used for research of diseases caused by accelerated apoptosis .
loading...
    loading...
Cat. No.: HY-P10076
Synonyms: L-HIV-Tat(48–57)-PP-JBD20
Target:  

JNK

Research Areas:  

Metabolic Disease

TAT-JBD20 (L-HIV-TAT(48–57)-PP-JBD20) is a JNK peptide inhibitor. TAT-JBD20 can be used for research of diabetes .
loading...
    loading...
Cat. No.: HY-P5320A
Target:  

Apoptosis

Research Areas:  

Others

TAT-BH4 (Bcl-xL) TFA is localized mainly at the mitochondria, prevents apoptotic cell death. TAT-BH4 (Bcl-xL) is a fusion peptide that combines the N-terminal cysteine conjugated protein transduction domain of HIV TAT protein (amino acids 49 to 57) with the Bcl-xL BH4 peptide. TAT-BH4 TFA can be used for research of diseases caused by accelerated apoptosis .
loading...
    loading...
Cat. No.: HY-P83141
Synonyms: HTatSF1; 17S U2 SnRNP complex component HTatSF1; HIV Tat-specific factor 1

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP

Reactivity:  

Human, Mouse

loading...
    loading...